Cure My Disease

Don't miss your cure!

 Log in / Sign up

New drug YL242 takes on advanced solid tumors in first human trial

NCT ID NCT07197827

Recruiting now Disease control Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new drug called YL242, given alone or with other treatments, for adults with advanced solid tumors that have not responded to prior therapy. The main goals are to check safety and see if tumors shrink. About 424 participants will take part in this early-phase trial.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC HER2-NEGATIVE GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

colorectal cancer gastroesophageal junction adenocarcinoma hepatocellular carcinoma neoplasm non-small cell lung carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADVANCED SOLID TUMOR

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • AUS-101

    NOT_YET_RECRUITING

    Liverpool, New South Wales, 2170, Australia

  • AUS-102

    RECRUITING

    Darlinghurst, Victoria, 2010, Australia

  • AUS-103

    NOT_YET_RECRUITING

    Heidelberg, Victoria, 3084, Australia

  • AUS-104

    NOT_YET_RECRUITING

    Fitzroy, Victoria, 3065, Australia

  • AUS-105

    NOT_YET_RECRUITING

    Nedlands, Western Australia, 6009, Australia

  • CN-301

    RECRUITING

    Shanghai, Shanghai Municipality, 200030, China

  • CN-302

    RECRUITING

    Hangzhou, Zhejiang, 310022, China

  • CN-303

    RECRUITING

    Harbin, Heilongjiang, 150081, China

  • US-201

    NOT_YET_RECRUITING

    New Haven, Connecticut, 06519, United States

  • US-202

    RECRUITING

    Sarasota, Florida, 34232, United States

  • US-203

    NOT_YET_RECRUITING

    Houston, Texas, 77030, United States

  • US-204

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

  • US-205

    RECRUITING

    Nashville, Tennessee, 37203, United States

  • US-206

    RECRUITING

    Grand Rapids, Michigan, 49546, United States

  • US-207

    NOT_YET_RECRUITING

    San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.